Department of Cardiology, University Clinical Hospital of Santiago de Compostela, A Coruña, Spain.
JACC Cardiovasc Interv. 2012 Nov;5(11):1117-25. doi: 10.1016/j.jcin.2012.06.023.
This study sought to compare the in-hospital prognostic values of the original and updated GRACE (Global Registry of Acute Coronary Events) risk score (RS) and the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] Registry and the GWTG [Get With the Guidelines] Database) RS in acute coronary syndromes (ACS). To evaluate the utility of recalculating risk after percutaneous coronary intervention (PCI) with newer RS models (NCDR [National Cardiovascular Data Registry] and EHS [EuroHeart Score] RS).
Defined in 2003, GRACE is among the most popular systems of risk stratification in ACS. An updated version of GRACE has since appeared and new RS have been developed, aiming to improve risk prediction.
From 2004 to 2010, 4,497 consecutive patients admitted to a single center in Spain with an ACS were included (32.1% ST-segment elevation myocardial infarction, 19.2% unstable angina). Discrimination (C-statistic) and calibration (Hosmer-Lemeshow [HL]) indexes were used to assess performance of each RS. A comparative analysis of RS designed to predict post-PCI mortality NCDR and EHS RS versus the GRACE and AR-G RS was performed in a subgroup of 1,113 consecutive patients included in the study.
There were 265 in-hospital deaths (5.9%). Original and updated GRACE RS and the AR-G RS all demonstrated good discrimination for in-hospital death (C-statistics: 0.91, 0.90 and 0.90, respectively) with optimal calibration (HL p: 0.42, 0.50, and 0.47, respectively) in all spectra of ACS, according to different managements (PCI vs. conservative) and without significant differences between the 3 different RS. In patients undergoing PCI, EHS and NCDR RS (C-statistic = 0.80 and 0.84, respectively) were not superior to GRACE RS (C-statistic = 0.91), albeit in the subgroup of patients undergoing PCI who were categorized as high risk using the GRACE RS, both EHS and NCDR have contributed to decrease the false positive rate generated by using the GRACE RS.
Despite having been developed over 8 years ago, the GRACE RS still maintains its excellent performance for predicting in-hospital risk of death among ACS patients.
本研究旨在比较原始和更新的 GRACE(全球急性冠状动脉事件注册)风险评分(RS)和 AR-G(ACTION [急性冠状动脉治疗和干预结果网络]注册和 GWTG [遵循指南]数据库)RS 在急性冠状动脉综合征(ACS)中的院内预后价值。评估使用更新的 RS 模型(NCDR [国家心血管数据注册]和 EHS [欧洲心脏评分] RS)重新计算经皮冠状动脉介入治疗(PCI)后风险的效用。
GRACE 于 2003 年定义,是 ACS 中最受欢迎的风险分层系统之一。此后出现了更新版本的 GRACE,并开发了新的 RS,旨在提高风险预测能力。
2004 年至 2010 年,纳入西班牙一家单中心收治的 4497 例连续 ACS 患者(32.1%ST 段抬高型心肌梗死,19.2%不稳定型心绞痛)。使用判别(C 统计量)和校准(Hosmer-Lemeshow [HL])指数评估每个 RS 的性能。对旨在预测 PCI 后死亡率的 RS 进行了比较分析,NCDR 和 EHS RS 与 GRACE 和 AR-G RS 相比,在研究纳入的 1113 例连续患者亚组中进行了比较。
院内死亡 265 例(5.9%)。原始和更新的 GRACE RS 和 AR-G RS 均能较好地预测院内死亡(C 统计量分别为 0.91、0.90 和 0.90),在 ACS 的不同管理(PCI 与保守)中具有最佳的校准(HL p:分别为 0.42、0.50 和 0.47),与 3 种不同 RS 之间无显著差异。在接受 PCI 治疗的患者中,EHS 和 NCDR RS(C 统计量分别为 0.80 和 0.84)并不优于 GRACE RS(C 统计量为 0.91),尽管在 GRACE RS 被归类为高危的 PCI 治疗患者亚组中,EHS 和 NCDR 有助于降低使用 GRACE RS 产生的假阳性率。
尽管 GRACE RS 是 8 年前开发的,但它仍然保持着预测 ACS 患者院内死亡风险的优异性能。